WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new ...
Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to ...
Endogenous RNA is central to protein control and, ultimately, cellular function. Synthetic RNA is an important tool for biological research and is also offering a new generation of promising ...
What keeps Joseph Makowiecki excited is the recurrent need for multilayered connectivity in bioprocess development and manufacturing, particularly when it comes to new therapeutic modalities, flexible ...
A pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of ...
Join host Neil Lander on Chromatography Life as he interviews, Arnaud Delobel, R&D and Innovation Director at Quality Assistance. They discuss the challenges of chromatographic analysis for new ...
AMSTERDAM, April 24, 2025 (GLOBE NEWSWIRE) -- Avidicure, a biotechnology company pioneering an entirely new multifunctional antibody modality with broad applicability in oncology, today announced its ...
BERKELEY, Calif.--(BUSINESS WIRE)--Novartis and the University of California, Berkeley have extended their research-based collaboration to develop new technologies for the discovery of next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback